What is treatment success in cardiac resynchronization therapy?

被引:58
作者
Foley, Paul W. X. [1 ]
Leyva, Francisco [1 ]
Frenneaux, Michael P. [1 ]
机构
[1] Univ Birmingham, Queen Elizabeth Hosp, Dept Cardiol, Ctr Cardiovasc Sci, Birmingham B15 2TH, W Midlands, England
来源
EUROPACE | 2009年 / 11卷
关键词
Cardiac resynchronization therapy; Mortality; Responders; BRAIN NATRIURETIC PEPTIDE; CONGESTIVE-HEART-FAILURE; LONG-TERM SURVIVAL; DIASTOLIC VENTRICULAR INTERACTION; EXERCISE OXYGEN-CONSUMPTION; SURROGATE END-POINTS; 6-MINUTE WALK TEST; SYSTOLIC FUNCTION; PROGNOSTIC VALUE; CLINICAL-TRIALS;
D O I
10.1093/europace/eup308
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiac resynchronization therapy (CRT) is an established treatment for symptomatic patients with heart failure, a prolonged QRS duration, and impaired left ventricular (LV) function. Identification of 'responders' and 'non-responders' to CRT has attracted considerable attention. The response to CRT can be measured in terms of symptomatic response or clinical outcome, or both. Alternatively, the response to CRT can be measured in terms of changes in surrogate measures of outcome, such as LV volumes, LV ejection fraction, invasive measures of cardiac performance, peak oxygen uptake, and neurohormones. This review explores whether these measures can be used in assessing the symptomatic and prognostic response to CRT. The role of these parameters to the management of individual patients is also discussed.
引用
收藏
页码:58 / 65
页数:8
相关论文
共 83 条
[61]   Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review [J].
Olsson, LG ;
Swedberg, K ;
Clark, AL ;
Witte, KK ;
Cleland, JGF .
EUROPEAN HEART JOURNAL, 2005, 26 (08) :778-793
[62]   Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure [J].
Packer, M .
JOURNAL OF CARDIAC FAILURE, 2001, 7 (02) :176-182
[63]   The effect of spironolactone on morbidity and mortality in patients with severe heart failure [J].
Pitt, B ;
Zannad, F ;
Remme, WJ ;
Cody, R ;
Castaigne, A ;
Perez, A ;
Palensky, J ;
Wittes, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) :709-717
[64]   Prognostic value of brain natriuretic peptide in the management of patients receiving cardiac resynchronization therapy [J].
Pitzalis, Maria Vittoria ;
Iacoviello, Massimo ;
Di Serio, Francesca ;
Romito, Roberta ;
Guida, Pietro ;
De Tommasi, Elisabetta ;
Luzzi, Giovanni ;
Anaclerio, Matteo ;
Varraso, Lucia ;
Forleo, Cinzia ;
Pansini, Nicola .
EUROPEAN JOURNAL OF HEART FAILURE, 2006, 8 (05) :509-514
[65]   SURROGATE ENDPOINTS IN CLINICAL-TRIALS - DEFINITION AND OPERATIONAL CRITERIA [J].
PRENTICE, RL .
STATISTICS IN MEDICINE, 1989, 8 (04) :431-440
[66]   Reduced ventricular volumes and improved systolic function with cardiac resynchronization therapy - A randomized trial comparing simultaneous biventricular pacing, sequential biventricular pacing, and left ventricular pacing [J].
Rao, Rajni K. ;
Kumar, Uday N. ;
Schafer, Jill ;
Viloria, Esperanza ;
De Lurgio, David ;
Foster, Elyse .
CIRCULATION, 2007, 115 (16) :2136-2144
[67]   Prognostic value of 6-minute walk corridor test in patients with mild to moderate heart failure: comparison with other methods of functional evaluation [J].
Rostagno, C ;
Olivo, G ;
Comeglio, M ;
Boddi, V ;
Banchelli, M ;
Galanti, G ;
Gensini, GF .
EUROPEAN JOURNAL OF HEART FAILURE, 2003, 5 (03) :247-252
[68]   Echocardiographic evaluation of mitral geometry in functional mitral regurgitation [J].
Sadeghpour, Anita ;
Abtahi, Firoozeh ;
Kiavar, Majid ;
Esmaeilzadeh, Maryam ;
Samiei, Niloofar ;
Ojaghi, Seyedeh Zahra ;
Bakhshandeh, Hooman ;
Maleki, Majid ;
Noohi, Feridoun ;
Mohebbi, Ahmad .
JOURNAL OF CARDIOTHORACIC SURGERY, 2008, 3 (1)
[69]   Peak oxygen consumption and outcome in heart failure patients chronically treated with β-blockers [J].
Shakar, SF ;
Lowes, BD ;
Lindenfeld, J ;
Zolty, R ;
Simon, M ;
Robertson, AD ;
Bristow, MR ;
Wolfel, EE .
JOURNAL OF CARDIAC FAILURE, 2004, 10 (01) :15-20
[70]   Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure [J].
Sutton, MGS ;
Plappert, T ;
Abraham, WT ;
Smith, AL ;
DeLurgio, DB ;
Leon, AR ;
Loh, E ;
Kocovic, DZ ;
Fisher, WG ;
Ellestad, M ;
Messenger, J ;
Kruger, K ;
Hilpisch, KE ;
Hill, MRS .
CIRCULATION, 2003, 107 (15) :1985-1990